Global Retirement Partners, LLC Bristol Myers Squibb CO Transaction History

Global Retirement Partners, LLC

  • $2.65 Billion
  • Q1 2024

A detailed history of Global Retirement Partners, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Global Retirement Partners, LLC holds 20,045 shares of BMY stock, worth $794,984. This represents 0.04% of its overall portfolio holdings.

Number of Shares
20,045
Previous 19,716 1.67%
Holding current value
$794,984
Previous $1.01 Million 7.52%
% of portfolio
0.04%
Previous 0.04%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 23, 2024
BUY
$47.98 - $54.4 $15,785 - $17,897
329 Added 1.67%
20,045 $1.09 Million
Q4 2023

Jan 18, 2024
BUY
$48.48 - $57.85 $193 - $231
4 Added 0.02%
19,716 $1.01 Million
Q3 2023

Oct 13, 2023
SELL
$57.89 - $64.73 $58,758 - $65,700
-1,015 Reduced 4.9%
19,712 $1.14 Million
Q2 2023

Jul 20, 2023
BUY
$63.71 - $70.74 $100,215 - $111,274
1,573 Added 8.21%
20,727 $1.33 Million
Q1 2023

May 05, 2023
BUY
$65.71 - $74.53 $151,724 - $172,089
2,309 Added 13.71%
19,154 $1.33 Million
Q4 2022

Feb 13, 2023
BUY
$68.48 - $81.09 $70,055 - $82,955
1,023 Added 6.47%
16,845 $1.21 Million
Q4 2022

Feb 13, 2023
BUY
$68.48 - $81.09 $70,055 - $82,955
1,023 Added 6.47%
16,845 $1.21 Million
Q3 2022

Nov 03, 2022
BUY
$0.13 - $76.84 $18 - $10,988
143 Added 0.91%
15,822 $1.23 Million
Q2 2022

Jul 15, 2022
BUY
$72.62 - $79.98 $10,747 - $11,837
148 Added 0.95%
15,679 $1.21 Million
Q1 2022

Jul 14, 2022
BUY
$61.48 - $73.72 $954,845 - $1.14 Million
15,531 New
15,531 $1.2 Million
Q4 2021

Jan 21, 2022
SELL
$53.63 - $62.52 $424,374 - $494,720
-7,913 Closed
0 $0
Q3 2021

Oct 22, 2021
BUY
$59.17 - $69.31 $24,259 - $28,417
410 Added 5.46%
7,913 $468,000
Q2 2021

Jul 15, 2021
BUY
$61.91 - $67.42 $2,352 - $2,561
38 Added 0.51%
7,503 $501,000
Q1 2021

Apr 14, 2021
SELL
$59.34 - $66.74 $39,164 - $44,048
-660 Reduced 8.12%
7,465 $471,000
Q4 2020

Jan 13, 2021
SELL
$57.74 - $65.43 $313,470 - $355,219
-5,429 Reduced 40.05%
8,125 $504,000
Q3 2020

Oct 09, 2020
SELL
$57.43 - $63.64 $2,871 - $3,182
-50 Reduced 0.37%
13,554 $817,000
Q2 2020

Jul 13, 2020
SELL
$54.82 - $64.09 $52,188 - $61,013
-952 Reduced 6.54%
13,604 $800,000
Q1 2020

Apr 28, 2020
SELL
$46.4 - $67.43 $37,352 - $54,281
-805 Reduced 5.24%
14,556 $811,000
Q4 2019

Jan 23, 2020
BUY
$49.21 - $64.19 $66,384 - $86,592
1,349 Added 9.63%
15,361 $986,000
Q3 2019

Nov 19, 2019
BUY
$42.77 - $50.71 $31,778 - $37,677
743 Added 5.6%
14,012 $711,000
Q2 2019

Nov 19, 2019
BUY
$44.62 - $49.34 $202,217 - $223,608
4,532 Added 51.87%
13,269 $602,000
Q1 2019

May 07, 2019
BUY
$45.12 - $53.8 $6,361 - $7,585
141 Added 1.64%
8,737 $417,000
Q4 2018

Feb 22, 2019
SELL
$48.76 - $63.23 $50,125 - $65,000
-1,028 Reduced 10.68%
8,596 $447,000
Q3 2018

Oct 17, 2018
SELL
$55.19 - $62.25 $8,609 - $9,711
-156 Reduced 1.6%
9,624 $597,000
Q2 2018

Aug 13, 2018
BUY
$50.53 - $62.98 $34,663 - $43,204
686 Added 7.54%
9,780 $541,000
Q1 2018

Aug 10, 2018
SELL
$59.92 - $68.98 $243,634 - $280,472
-4,066 Reduced 30.9%
9,094 $575,000
Q4 2017

Aug 13, 2018
BUY
$59.94 - $65.35 $642,736 - $700,748
10,723 Added 440.01%
13,160 $806,000
Q3 2017

Aug 10, 2018
SELL
$55.23 - $63.74 $9,941 - $11,473
-180 Reduced 6.88%
2,437 $155,000
Q2 2017

Aug 10, 2018
BUY
N/A
200 Added 8.27%
2,617 $146,000
Q1 2017

Aug 10, 2018
BUY
N/A
16 Added 0.67%
2,417 $131,000
Q4 2016

Aug 10, 2018
BUY
N/A
2,401
2,401 $140,000

Others Institutions Holding BMY

# of Institutions
2,553
Shares Held
1.49B
Call Options Held
25.9M
Put Options Held
20M
View Full List

About BRISTOL MYERS SQUIBB CO

BMY Quotes by TradingView
  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $84.3B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Global Retirement Partners, LLC Portfolio

Follow Global Retirement Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Global Retirement Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Global Retirement Partners, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email